Eficacia de los bifosfonatos en la espondilitis anquilosante

More documents

Recommendations

Info

Urine or IL 1 Inhibitor Urine or Urine IL‐1 Inhibitor or IL‐1Ra or Antril or Synergen Brand of Anakinra or Anakinra Synergen Brand or Kineret or Amgen Brand of Anakinra or Anakinra Amgen Brand or Anakinra or Amtril or l 1ra or Interleukin 1 Antagonist or Interleukin 1ra or Interleukin 1 or Receptor Antagonist or Interleukin 1 Receptor Antagonist Protein).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer name] 32. 30 or 31 or 29 33. abatacept.mp. or ABATACEPT/ 34. (abatacept or belatacept or LEA29Y or BMS‐224818 or BMS‐224818 or ctla‐4‐ig cytotoxic t lymphocyte associated antigen 4‐ ig or orencia orbis 188667 or orbms‐188667 or Bms 188667 or Bms188667 or Ctla4 Ig or Ctla4ig or Ctla4 Immunoglobulin or Ctla4 Immunoglobulin G or Orencia).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer name] 35. abatacept.af. 36. 35 or 33 or 34 37. Cyclophosphamide.af. 38. CYCLOPHOSPHAMIDE DERIVATIVE/ or CYCLOPHOSPHAMIDE/ or Cyclophosphamide.mp. 39. cyclophosphan OR cyclophosphane OR procyon OR sendoxan OR neosar OR cyclophosphamide isomer OR cyclophosphamide AND isomer of cyclophosphamide AND (S) AND isomer OR cytoxan OR endoxan OR cyclophosphamide monohydrate OR monohydrate cyclophosphamide 40. 38 or 39 or 37 41. Cholrambucil.mp. or Chlorambucil/ 42. (Cholrambucil or Chlorambucil).af. 43. ((n, n di and 2‐chloroethyl and p aminophenylbutyric acid chlorbutin or4‐ and (Bis and 2‐ chloroethyl and amino)) or glaxosmithkline brand of chlorambucil or wellcome brand of chlorambucil or lympholysis or amboclorin or antineoplastic agents alkylating).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer name] 44. 42 or 43 or 41 45. 4 and 24 and 19 46. limit 45 to (human and (english or french or spanish)) 47. 46 and 13 talidomia_eficacia_artritispsoriásica 48. 8 and 24 and 19 49. limit 48 to (human and (english or french or spanish)) 50. 49 and 13 talidomia_eficacia_espondiloartropatías 51. 24 and 19 and 12 52. 51 and 13 53. limit 52 to (human and (english or french or spanish)) talidomia_eficacia_espondilitisankilosante 54. 4 and 28 and 19
55. 54 and 20 56. limit 55 to (human and (english or french or spanish)) bifosfonatos_eficacia_artritispsoriásica 57. 8 and 28 and 19 58. 57 and 20 59. limit 58 to (human and (english or french or spanish)) bifosfonatos_eficacia_espondiloartropatías 60. 28 and 19 and 12 61. 60 and 20 62. limit 61 to (human and (english or french or spanish)) bifosfonatos_eficacia_espondilitisankilosabte 63. 32 and 4 and 19 64. 63 and 20 65. limit 64 to (human and (english or french or spanish)) anakinra_eficacia_artritispsoriásica 66. 8 and 32 and 19 67. 66 and 20 68. limit 67 to (human and (english or french or spanish)) anakinra_eficacia_espondiloartropatías 69. 32 and 19 and 12 70. limit 69 to (human and (english or french or spanish)) 71. 70 and 20 anakinra_eficacia_espoondilitisankilosante 72. 4 and 36 and 19 73. limit 72 to (human and (english or french or spanish)) 74. 73 and 19 75. limit 74 to (human and (english or french or spanish)) abatacept_eficacia_artritispsoriásica 76. 8 and 36 and 19 77. 76 and 20 78. limit 77 to (human and (english or french or spanish)) abatacept_eficacia_espondiloartropatías 79. 36 and 19 and 12 80. limit 79 to (human and (english or french or spanish)) 81. 80 and 20 abatacept_eficacia_espondilitisankilosante 82. 4 and 40 and 19 83. 82 and 20 84. limit 83 to (human and (english or french or spanish)) ciclofosfamida_eficacia_artritispsoriásica 85. 8 and 40 and 19
Page 1 and 2: Eficacia de los bifosfonatos en la
Page 3 and 4: Systematic literature search of the
Page 5 and 6: Conclusiones: Los bifosfonatos podr
Page 7: Ankylopoietica or Spondylitis Ankyl

Eficacia de los bifosfonatos en la espondilitis anquilosante

Create successful ePaper yourself

Delete template?

Save as template?